Sarepta Therapeutics (SRPT) Stake Held by Venbio Select Advisor Llc; Elk Creek Partners Has Upped Boot Barn Hldgs (BOOT) Position

Boot Barn Holdings, Inc. (NYSE:BOOT) Logo

Elk Creek Partners Llc increased its stake in Boot Barn Hldgs Inc (BOOT) by 11.56% based on its latest 2018Q4 regulatory filing with the SEC. Elk Creek Partners Llc bought 45,866 shares as the company’s stock rose 29.06% with the market. The institutional investor held 442,549 shares of the consumer services company at the end of 2018Q4, valued at $7.54 million, up from 396,683 at the end of the previous reported quarter. Elk Creek Partners Llc who had been investing in Boot Barn Hldgs Inc for a number of months, seems to be bullish on the $805.39M market cap company. The stock increased 2.67% or $0.74 during the last trading session, reaching $28.43. About 622,707 shares traded. Boot Barn Holdings, Inc. (NYSE:BOOT) has risen 57.28% since March 12, 2018 and is uptrending. It has outperformed by 52.91% the S&P500. Some Historical BOOT News: 17/05/2018 – Boot Barn Holdings, Inc. Announces Launch of Public Offering by Selling Stockholders; 21/05/2018 – Fintel Insider Selling Report: Caesars Entertainment Corporation (CZR), Boot Barn Holdings, Inc. (BOOT), And Others; 15/05/2018 – Ivy Investment Management Company Buys 3.3% of Boot Barn; 15/05/2018 – BOOT BARN HOLDINGS INC BOOT.N SEES FY 2019 SHR $0.92 TO $1.02; 15/05/2018 – BOOT BARN HOLDINGS INC – QTRLY NET SALES INCREASED TO $170.8 MLN, DRIVEN BY A 12.1% INCREASE IN SAME STORE SALES; 15/05/2018 – Tiger Management Buys New 2.9% Position in Boot Barn; 15/05/2018 – BOOT BARN HOLDINGS INC BOOT.N : JP MORGAN RAISES TARGET PRICE TO $26 FROM $22; 24/04/2018 – Boot Barn Holdings, Inc. Acquires Three-Store Boot Chain In Texas; 15/05/2018 – Boot Barn Holdings Expects to Open 23 New Stores in FY19; 22/04/2018 – DJ Boot Barn Holdings Inc, Inst Holders, 1Q 2018 (BOOT)

Venbio Select Advisor Llc increased its stake in Sarepta Therapeutics Inc (SRPT) by 35.14% based on its latest 2018Q4 regulatory filing with the SEC. Venbio Select Advisor Llc bought 331,500 shares as the company’s stock rose 13.40% with the market. The institutional investor held 1.28 million shares of the health care company at the end of 2018Q4, valued at $139.14M, up from 943,500 at the end of the previous reported quarter. Venbio Select Advisor Llc who had been investing in Sarepta Therapeutics Inc for a number of months, seems to be bullish on the $9.93B market cap company. The stock increased 2.74% or $3.59 during the last trading session, reaching $134.39. About 1.23M shares traded. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) has risen 134.23% since March 12, 2018 and is uptrending. It has outperformed by 129.86% the S&P500. Some Historical SRPT News: 08/05/2018 – OncoSec Expands Relationship with Merck, Announces Clinical Collaboration to Evaluate Combination of lmmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Triple Negative Breast Cancer; 31/05/2018 – Phase l/Il Study Design of Birinapant in Combination With Keytruda® to be Presented on June 4 at the ASCO Annual Meeting; 16/04/2018 – NEARLY 70 PCT OF KEYTRUDA PLUS CHEMOTHERAPY PATIENTS ALIVE AFTER 1 YEAR VS 49 PCT FOR CHEMO ALONE – DATA; 30/04/2018 – MRK: SBLA FOR KEYTRUDA COMBO WITH ALIMTA AND PLATINUM CHEMO; 09/04/2018 – KEYTRUDA® (PEMBROLIZUMAB) MONOTHERAPY MET PRIMARY ENDPOINT IN PHASE 3 KEYNOTE-042 STUDY, SIGNIFICANTLY IMPROVING OS AS FIRST-LINE THERAPY IN LOCALLY ADVANCED OR METASTATIC NSCLC PATIENTS EXPRESSING P…; 16/05/2018 – Merck’s Keytruda boosts response in hard-to-treat lung cancer; 12/03/2018 – Sarepta Therapeutics Met With FDA in Feb to Obtain Guidance on Regulatory Pathway for Golodirsen; 09/04/2018 – MERCK & CO INC – SAFETY PROFILE OF KEYTRUDA IN PHASE 3 TRIAL WAS CONSISTENT; 06/04/2018 – INCYTE CORP – EDMC REVIEW OF PHASE 3 ECHO-301/KEYNOTE-252 STUDY EVALUATING EPACADOSTAT WITH KEYTRUDA DETERMINED STUDY DID NOT MEET PRIMARY ENDPOINT; 30/04/2018 – Merck: FDA Grants Priority Review to sBLA for Keytruda Combination

Investors sentiment decreased to 1.61 in 2018 Q4. Its down 0.04, from 1.65 in 2018Q3. It dropped, as 27 investors sold BOOT shares while 34 reduced holdings. 40 funds opened positions while 58 raised stakes. 28.45 million shares or 1.06% more from 28.15 million shares in 2018Q3 were reported. Fuller & Thaler Asset Mngmt invested in 271,235 shares. Chicago Equity Prtnrs Ltd Liability stated it has 0.03% of its portfolio in Boot Barn Holdings, Inc. (NYSE:BOOT). Thompson Siegel And Walmsley Ltd has 95,129 shares for 0.03% of their portfolio. Tci Wealth holds 0% or 33 shares. Hillsdale Inv Mngmt Inc has invested 0.05% in Boot Barn Holdings, Inc. (NYSE:BOOT). Parametric Assocs Llc reported 0% stake. Credit Suisse Ag holds 0% of its portfolio in Boot Barn Holdings, Inc. (NYSE:BOOT) for 53,891 shares. Art Advsrs Ltd Limited Liability Company invested in 0.13% or 116,337 shares. Invesco Ltd owns 39,048 shares. Elk Creek Prtn Ltd Liability Corporation accumulated 442,549 shares. Shellback Capital Limited Partnership reported 1.08% in Boot Barn Holdings, Inc. (NYSE:BOOT). 27,050 are owned by Coe Management Limited. Acadian Asset Mgmt Limited Liability reported 135,164 shares. Us Bank De owns 3,344 shares. Walleye Trading Limited Company holds 0% in Boot Barn Holdings, Inc. (NYSE:BOOT) or 19,031 shares.

Elk Creek Partners Llc, which manages about $800.79 million and $1.21B US Long portfolio, decreased its stake in Carrizo Oil & Gas Inc (NASDAQ:CRZO) by 68,388 shares to 403,819 shares, valued at $4.56 million in 2018Q4, according to the filing. It also reduced its holding in Trimble Inc (NASDAQ:TRMB) by 51,537 shares in the quarter, leaving it with 107,993 shares, and cut its stake in World Wrestling Entmt Inc (NYSE:WWE).

More notable recent Boot Barn Holdings, Inc. (NYSE:BOOT) news were published by: Benzinga.com which released: “5 Stocks To Watch For January 14, 2019 – Benzinga” on January 14, 2019, also Schaeffersresearch.com with their article: “Boot Barn’s “Game Changer”; SNAP Shares Recover – Schaeffers Research” published on October 11, 2018, Seekingalpha.com published: “Stocks To Watch: Big Intros For Model Y And Captain Marvel? – Seeking Alpha” on March 09, 2019. More interesting news about Boot Barn Holdings, Inc. (NYSE:BOOT) were released by: Investorplace.com and their article: “Too Early or Too Late? General Electric Stock Has Investors Guessing – Investorplace.com” published on March 11, 2019 as well as Seekingalpha.com‘s news article titled: “Guess?: A 4%+ Yield And Growth To Boot – Seeking Alpha” with publication date: December 31, 2018.

Since October 24, 2018, it had 1 buy, and 7 sales for $38.17 million activity. Howton David T sold $4.20 million worth of stock. BEHRENS M KATHLEEN sold $1.32M worth of stock or 10,000 shares. Mahatme Sandesh also sold $9.43 million worth of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) on Thursday, February 7. On Thursday, November 1 the insider Wigzell Hans Lennart Rudolf sold $936,714. 16,695 Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares with value of $2.01M were bought by INGRAM DOUGLAS S.

Venbio Select Advisor Llc, which manages about $380.08M and $1.67 billion US Long portfolio, decreased its stake in Horizon Pharma Plc (NASDAQ:HZNP) by 110,426 shares to 4.35 million shares, valued at $85.00 million in 2018Q4, according to the filing. It also reduced its holding in Biomarin Pharmaceutical Inc (NASDAQ:BMRN) by 8,103 shares in the quarter, leaving it with 1.36 million shares, and cut its stake in Intec Pharma Ltd.

Investors sentiment decreased to 1.08 in Q4 2018. Its down 0.22, from 1.3 in 2018Q3. It is negative, as 46 investors sold SRPT shares while 85 reduced holdings. 48 funds opened positions while 93 raised stakes. 65.70 million shares or 11.45% more from 58.95 million shares in 2018Q3 were reported. Millennium Mngmt Lc holds 151,405 shares or 0.03% of its portfolio. Tekla Management Limited Liability Co, a Massachusetts-based fund reported 191,837 shares. Granite Point Capital LP invested in 0.45% or 20,500 shares. Ghost Tree Cap Ltd Liability Company holds 2.68% or 70,000 shares. Waddell And Reed Financial holds 0.37% or 1.18M shares in its portfolio. Farallon Cap Management Ltd Llc reported 640,000 shares. Venbio Select Advisor Ltd Liability Company invested in 8.32% or 1.28M shares. Bank Of Ny Mellon holds 0.02% in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) or 570,668 shares. National Bank Of America Corp De holds 460,591 shares. 2,464 were accumulated by Stevens Mgmt Ltd Partnership. Moreover, Ny State Common Retirement Fund has 0.02% invested in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) for 133,315 shares. Pnc Fincl Service Gp Inc reported 80,673 shares. Lord Abbett And Llc has invested 0.13% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). 4.39 million are held by Price T Rowe Assocs Inc Md. C Gru Hldg A S holds 0.06% of its portfolio in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) for 34,968 shares.

More notable recent Sarepta Therapeutics, Inc. (NASDAQ:SRPT) news were published by: Nasdaq.com which released: “Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53 – Nasdaq” on February 14, 2019, also Nasdaq.com with their article: “Too Much Talking, Not Enough Action – Nasdaq” published on February 28, 2019, Nasdaq.com published: “June 21st Options Now Available For Sarepta Therapeutics (SRPT) – Nasdaq” on February 01, 2019. More interesting news about Sarepta Therapeutics, Inc. (NASDAQ:SRPT) were released by: Benzinga.com and their article: “Barron’s On: Pharma’s Big Hope (NYSE:PFE)(NASDAQ:SRPT)(NASDAQ:CRSP) – Benzinga” published on March 03, 2019 as well as Nasdaq.com‘s news article titled: “First Week of SRPT March 15th Options Trading – Nasdaq” with publication date: January 29, 2019.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.